Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817199-26-000030 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
17,361
Total Value
$199,534.99
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Sep 2, 2026 | Exercise/Conversion | 5,787 | $8.72 | $50,462.64 | 14,897 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Sep 2, 2026 | Sale | 5,387 | $25.69 | $138,417.35 | 9,510 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Sep 2, 2026 | Sale | 400 | $26.64 | $10,655.00 | 9,110 | Direct | โ | View Details | |
Chief Legal Officer | Employee Stock Option (right to buy) | Derivative | Sep 2, 2026 | Exercise/Conversion | 5,787 | $0.00 | $0.00 | 117,037 | Direct | โ | View Details |